Tracker / Internal generative AI platforms

Internal generative AI platforms

Last updated: September 29, 2026 · 16 platforms from 14 companies · Every row links to a sourced Pharma AI Tracker entry · Changelog

The platforms at a glance

Rows are in-house employee platforms with a Tracker entry. See the method. Assistant and Agent builder are our grouping, not company labels. Figures are not ranked. Order is company A to Z, then platform name.

What each company has disclosed

Merck & Co.: GPTeal

GPTeal is Merck & Co.'s proprietary generative AI platform. It uses models including OpenAI's ChatGPT, Meta's Llama, and Anthropic's Claude, and gives employees four GenAI products, including an internal chatbot and document translation. Merck & Co. said 43,000 employees were using it and had entered 80 million prompts. First disclosed Oct 2024. GPTeal entry.

Merck KGaA: myGPT Suite

myGPT Suite is Merck KGaA's internal generative AI platform. Merck KGaA is a different company from Merck & Co. No model provider is named. The 2025 annual report gives 32,000+ monthly active users, over half the workforce, and >90% cost savings vs off-the-shelf. First disclosed Mar 2026. myGPT Suite entry.

Sanofi: Concierge

Concierge is Sanofi's internally hosted generative AI companion. No model provider is named. It helps employees find answers, navigate tools, and automate routine tasks. Sanofi launched it in October 2024. The filing says it supports over 30,000 users and saves two hours per user per week on average. First disclosed Feb 2026. Concierge entry.

Pfizer: Vox

Vox is Pfizer's internally approved generative AI platform, built on AWS. AWS says it gives colleagues secure access to large language models, including Amazon Bedrock and Amazon SageMaker (vendor claim). No user count is disclosed. No launch date is given. First disclosed Nov 2023. Vox entry.

Moderna: mChat

mChat is Moderna's in-house generative AI chat tool. No model provider is named. Moderna says it launched in May 2023 after two weeks of development. Nearly 65% of employees were active users in Oct 2023. First disclosed Nov 2023. mChat entry.

Daiichi Sankyo: DS-GAI

DS-GAI is Daiichi Sankyo's in-house generative AI system. No model provider is named. It chats over files and internal data, and it can generate images. More than half of employees in Japan have experienced it, and average daily users are over 600. First disclosed Jul 2024. DS-GAI entry.

Takeda: myAibou and Self-Service AI Foundation

myAibou is Takeda's digital assistant. Early users had it draft emails and analyze content. No model is named. It only sees data users put into their prompts. First disclosed Jul 2024. Self-Service AI Foundation, on Databricks, lets over 10,000 employees build and run agents, with a control tower and a marketplace. Provisioning was cut from 60 to 70 support tickets to one-click approval. First disclosed Jun 2026. See myAibou and Self-Service AI Foundation.

UCB: SKAI

Microsoft says UCB created SKAI, an internal generative AI platform built on Microsoft Azure with Azure OpenAI. It powers assistants from medical writing to clinical statistics. No SKAI user count is disclosed. The same page has a UCB speaker anticipating Microsoft 365 Copilot active use moving from 50% to 80% of employees, which is about Copilot, not SKAI (vendor claim). First disclosed Nov 2025. SKAI entry.

GSK: AIGA

AIGA is an internal framework for generative AI and agentic solutions. Weights & Biases says GSK and Microsoft built it (vendor claim). Partners named are Microsoft and Weights & Biases. No user count is disclosed. First disclosed Nov 2025. AIGA entry.

Novo Nordisk: NN ChatGPT and the Bedrock chatbot platform

NN ChatGPT is Novo Nordisk's internal ChatGPT and other generative AI tools, named in a 2024 deck. No model or user count is disclosed. First disclosed Mar 2024. Employees also build chatbots on Amazon Bedrock, with AWS and Cloud2 Oy. AWS reports 2,500 chatbots created and more than 25,000 employees using it (vendor claim). First disclosed Jan 2026. See NN ChatGPT and the Bedrock platform.

Bristol Myers Squibb: in-house ChatGPT and GenAI tools

Bristol Myers Squibb describes private in-house ChatGPT and GenAI tools. No model provider is named. Employees upload documents, summarize information, plan projects, and find company information. No user count or launch date is disclosed. First disclosed Nov 2024. In-house ChatGPT entry.

Insmed: InQuiry

InQuiry is Insmed's proprietary generative AI assistant. No model provider is named. It uses internal data to summarize documents, create content, and produce meeting recaps. The 2025 annual report says Insmed launched it in early 2025. No user count is disclosed. First disclosed Apr 2026. InQuiry entry.

Vertex: VAIDA

VAIDA is a multi-agent assistant Microsoft describes, built with Azure Logic Apps Agent Loop. It pulls knowledge from many internal systems so employees can find information faster. No user count is disclosed. The account is a vendor claim. First disclosed Nov 2025. VAIDA entry.

AstraZeneca: AI Agent Builder

AI Agent Builder sits in AstraZeneca's company-wide AI upskilling program. No model provider is named. Accredited employees get early access. AstraZeneca reports 1,500+ agents built in the first two months, and 37,700+ employees in the AI program. First disclosed Oct 2025. AI Agent Builder entry.

Built vs bought

Several companies do both. Merck & Co. has GPTeal and a Google Cloud deal valued at up to $1 billion. Sanofi has Concierge, company-wide Claude (vendor claim), and a Copilot pilot it did not scale. Moderna has mChat and ChatGPT Enterprise with 750+ GPTs. Novo Nordisk has internal tools and Microsoft 365 Copilot for 20,000 employees. This page does not rank them.

Bought rather than built

• Amgen: ChatGPT Enterprise. Adopted early and widened across the company in phases, with security controls. Disclosed Aug 2025.
• Amgen: Microsoft 365 Copilot. Access grew from a small group of employees experimenting with Copilot to 20,000 employees with access. Disclosed May 2024.
• Moderna: ChatGPT Enterprise and custom GPTs. A company-wide rollout with 750+ custom GPTs across legal, research, manufacturing, and commercial. Disclosed Apr 2024.
• Novo Nordisk: Microsoft 365 Copilot. MIT Sloan Management Review describes a rollout starting in early 2024 that reached 20,000 employees, with 2.17 hours saved per employee per week on average. Disclosed Jul 2025.
• Sanofi: Microsoft 365 Copilot pilot. Fortune reports that the chief digital officer did not make Copilot widely available after a small pilot. Disclosed May 2026.
• Sanofi: Claude company-wide. The chief digital officer says Claude is used daily by most employees (vendor claim). Disclosed Jan 2026.
• Bristol Myers Squibb: Claude Enterprise. An announced deployment of Claude, including Claude Code and agentic workflows, for more than 30,000 employees. Disclosed May 2026.
• Merck & Co.: Gemini Enterprise partnership. A joint release on a multi-year Google Cloud deal, valued at up to $1 billion, to deploy an agentic platform across R&D, manufacturing, commercial, and corporate teams. Disclosed Apr 2026.
• Genmab: AI Everywhere. A partnership so more than 2,000 colleagues can use ChatGPT. Disclosed Feb 2025.
• Pfizer: Copilot Studio agents. Microsoft reports 300+ Copilot Studio agents deployed across the company (vendor claim). Disclosed Nov 2025.

From chat assistants to agent builders

Takeda's Self-Service AI Foundation on Databricks lets over 10,000 employees build and run agents. Novo Nordisk's Bedrock platform has 2,500 chatbots created and more than 25,000 employees using it (vendor claim). AI Agent Builder produced 1,500+ agents in the first two months. SKAI is a family of assistants from medical writing to clinical statistics (vendor claim). VAIDA is a multi-agent assistant (vendor claim). Pfizer has 300+ Copilot Studio agents (vendor claim).

What these disclosures don't say

Disclosures rarely cover routing, gateways, audit trails, or validation status. myAibou only sees data users put into prompts. This page makes no claim about which of these tools may handle GxP data. See the GenAI routing layer, which reports no gateway or routing terms in Tracker entries, an LLM gateway from scratch, how a CSV validator should review an LLM gateway, an ALCOA+ audit trail for LLM calls, how much validation your AI needs, AI validation in GxP, and security as a GMP requirement.

FAQ

Which pharma companies have built their own internal ChatGPT?

Merck & Co. (GPTeal), Merck KGaA (myGPT Suite), Sanofi (Concierge), Pfizer (Vox), and Moderna (mChat) are five of them. This page lists 16 platforms from 14 companies. Last updated September 29, 2026. Each row links to a Tracker entry in the table.

What is Merck & Co.'s GPTeal?

GPTeal is Merck & Co.'s proprietary generative AI platform. It uses models including OpenAI's ChatGPT, Meta's Llama, and Anthropic's Claude. Merck & Co. said 43,000 employees were using it and had entered 80 million prompts, in a press interview disclosed Oct 2024. See the GPTeal entry.

Is GPTeal the same as myGPT Suite?

No. GPTeal belongs to Merck & Co. The press interview disclosed Oct 2024 gives 43,000 employees and 80 million prompts. myGPT Suite belongs to Merck KGaA, a different company. Its 2025 annual report, disclosed Mar 2026, gives 32,000+ monthly active users. See the GPTeal entry and the myGPT Suite entry.

Do pharma companies build or buy their GenAI tools?

Both, often at the same company. Merck & Co. has GPTeal and a Google Cloud deal for Gemini Enterprise, disclosed Apr 2026. Sanofi has Concierge and company-wide Claude use, plus a Copilot pilot it did not scale. See the GPTeal entry and the Concierge entry.

Can employees use these tools with GxP data?

Public disclosures rarely state a validation status or a data limit, so there is no yes or no here. myAibou only sees data users put into prompts, disclosed Jul 2024. See how much validation your AI needs and the GenAI routing layer.

How current is this list?

Last updated September 29, 2026. That is the newest verified date on this table. Updated monthly. Each row shows the date that entry was last verified. Additions and corrections are in the changelog. The verified dates are on the rows themselves.

How this page is maintained

This page uses the Tracker method, plus one rule of its own: a public source must describe an employee-facing platform built or branded in-house. Last updated September 29, 2026. See the changelog. Suggest a platform.

Recent changes

• October 7, 2026: First version: 16 platforms from 14 companies